• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Jim Cramer Looks At Blackstone, Praises MercadoLibre: 'They're Incredibly Smart'

    2/9/24 8:33:43 AM ET
    $ABBV
    $BX
    $FCX
    $MELI
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Investment Managers
    Finance
    Get the next $ABBV alert in real time by email

    On CNBC’s "Mad Money Lightning Round," Jim Cramer said Freeport-McMoRan Inc. (NYSE:FCX) could go higher by a "couple of points, once the Chinese start manipulating their market higher, but that’s all you’re going to get from them. We have to go higher quality."

    Freeport-McMoRan confirmed that Kathleen L. Quirk as its incoming president and CEO. The decision will be effective as of June 11.

    AbbVie Inc. (NYSE:ABBV) is a "very good" company, the "Mad Money" host said.

    AbbVie announced that its treatment for advanced Parkinson's disease is now available in Canada.

    Cramer said he was an original investor in MercadoLibre, Inc. (NASDAQ:MELI), and has never once abandoned it. "Those people are incredibly smart," he added.

    MercadoLibre, during November, reported better-than-expected third-quarter financial results.

    Don’t forget to check out our premarket coverage here

    When asked about Oxford Lane Capital Corp. (NASDAQ:OXLC), he said, "We don’t know if they’re any good at credit, and we don’t know what they own. I like the concept, and in that sense, I think I would look at Blackstone (NYSE:BX), because they really know how to do it."

    Oxford Lane Capital issued net asset value update for January. Management’s unaudited estimate of the range of the NAV per share of common stock as of Jan. 31, 2024 is between $4.92 and $5.02.

    Price Action:

    • Shares of Oxford Lane Capital gained 1.3% to close at $5.39 on Thursday.
    • AbbVie shares fell 0.1% to $174.79 on Thursday.
    • MercadoLibre shares rose 1.1% to settle at $1,732.83 during Thursday’s session.
    • Shares of Freeport-McMoRan fell 2.8% to close at $38.12 on Thursday.

    Now Read This: Top 5 Energy Stocks That May Explode In February

    Image: Shutterstock

    Get the next $ABBV alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABBV
    $BX
    $FCX
    $MELI

    CompanyDatePrice TargetRatingAnalyst
    AbbVie Inc.
    $ABBV
    2/25/2026$260.00Outperform
    RBC Capital Mkts
    Blackstone Inc.
    $BX
    2/24/2026$179.00Outperform
    RBC Capital Mkts
    AbbVie Inc.
    $ABBV
    2/20/2026$275.00Overweight
    Barclays
    Freeport-McMoRan Inc.
    $FCX
    2/13/2026Hold → Buy
    Argus
    MercadoLibre Inc.
    $MELI
    2/12/2026$2800.00Neutral → Overweight
    Analyst
    AbbVie Inc.
    $ABBV
    1/8/2026Outperform → Peer Perform
    Wolfe Research
    AbbVie Inc.
    $ABBV
    1/7/2026$240.00Neutral
    UBS
    Blackstone Inc.
    $BX
    12/11/2025$175.00Neutral
    UBS
    More analyst ratings

    $ABBV
    $BX
    $FCX
    $MELI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    RBC Capital Mkts initiated coverage on AbbVie with a new price target

    RBC Capital Mkts initiated coverage of AbbVie with a rating of Outperform and set a new price target of $260.00

    2/25/26 7:48:26 AM ET
    $ABBV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    RBC Capital Mkts initiated coverage on Blackstone with a new price target

    RBC Capital Mkts initiated coverage of Blackstone with a rating of Outperform and set a new price target of $179.00

    2/24/26 7:45:48 AM ET
    $BX
    Investment Managers
    Finance

    Barclays initiated coverage on AbbVie with a new price target

    Barclays initiated coverage of AbbVie with a rating of Overweight and set a new price target of $275.00

    2/20/26 8:23:14 AM ET
    $ABBV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABBV
    $BX
    $FCX
    $MELI
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for VYALEV issued to ABBVIE INC

    Submission status for ABBVIE INC's drug VYALEV (ORIG-1) with active ingredient FOSCARBIDOPA AND FOSLEVODOPA has changed to 'Approval' on 10/16/2024. Application Category: NDA, Application Number: 216962, Application Classification: Type 3 - New Dosage Form and Type 4 - New Combination

    10/18/24 4:38:13 AM ET
    $ABBV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for VYALEV issued to ABBVIE INC

    Submission status for ABBVIE INC's drug VYALEV (ORIG-1) with active ingredient FOSCARBIDOPA AND FOSLEVODOPA has changed to 'Approval' on 10/16/2024. Application Category: NDA, Application Number: 216962, Application Classification: Type 3 - New Dosage Form

    10/17/24 1:29:31 PM ET
    $ABBV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for SKYRIZI issued to ABBVIE INC

    Submission status for ABBVIE INC's drug SKYRIZI (SUPPL-7) with active ingredient RISANKIZUMAB-RZAA has changed to 'Approval' on 06/18/2024. Application Category: BLA, Application Number: 761262, Application Classification:

    6/21/24 4:38:17 AM ET
    $ABBV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABBV
    $BX
    $FCX
    $MELI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Blackstone Energy Transition Partners Announces Completion of 694MW Magnolia Power Generating Station in Louisiana

    Expected to Generate Enough Electricity to Power 500,000 Homes in Louisiana, Project Construction Created Over 400 Local Construction Jobs Blackstone (NYSE:BX) announced today that private equity funds managed by Blackstone Energy Transition Partners ("Blackstone") have completed construction of the Magnolia Power Generating Station ("Magnolia Power"), a 694-megawatt greenfield combined cycle gas turbine ("CCGT") power plant in Plaquemine, Louisiana. Today's announcement marks the beginning of commercial operations at the plant. Blackstone, through its North American power platform, Kindle Energy, started developing Magnolia Power in 2021, at a time when the digitization of data and AI

    2/26/26 12:30:00 PM ET
    $BX
    Investment Managers
    Finance

    MercadoLibre, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

    MercadoLibre, Inc. (NASDAQ:MELI) (http://www.mercadolibre.com) today reported financial results for the fourth quarter and full year ended December 31, 2025, in a Letter to Shareholders, which is now posted to the company's Investor Relations website https://investor.mercadolibre.com. The Company will host its earnings video conference, as well as a conference call and audio webcast for any questions that investors may have, on February 24, at 5:00 p.m. Eastern Time. In order to access our video webcast and the live audio, investors, analysts and the market in general may access the following link at https://event.choruscall.com/mediaframe/webcast.html?webcastid=0TZ2mrjz to attend the l

    2/24/26 4:02:00 PM ET
    $MELI
    Real Estate

    AbbVie to Present at the TD Cowen 46th Annual Health Care Conference

    NORTH CHICAGO, Ill., Feb. 24, 2026 /PRNewswire/ -- AbbVie (NYSE:ABBV) will participate in the TD Cowen 46th Annual Health Care Conference on Tuesday, March 3, 2026. Management will participate in a fireside chat at 10:10 a.m. Central Time. A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.About AbbVieAbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeuti

    2/24/26 8:00:00 AM ET
    $ABBV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABBV
    $BX
    $FCX
    $MELI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Blackstone Holdings Iv Gp Management (Delaware) L.P. bought $30,000,000 worth of Common Shares of Beneficial Interest (1,146,789 units at $26.16) (SEC Form 4)

    4 - Blackstone Inc. (0001393818) (Reporting)

    2/24/26 6:33:14 PM ET
    $BX
    Investment Managers
    Finance

    EVP & CAO Higgins Stephen T. sold $1,868,202 worth of shares (29,654 units at $63.00) (SEC Form 4)

    4 - FREEPORT-MCMORAN INC (0000831259) (Issuer)

    2/24/26 5:30:52 PM ET
    $FCX
    Metal Mining
    Basic Materials

    EVP, R&D and CSO Thakkar Roopal was granted 18,137 shares, increasing direct ownership by 43% to 60,413 units (SEC Form 4)

    4 - AbbVie Inc. (0001551152) (Issuer)

    2/20/26 6:36:48 PM ET
    $ABBV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABBV
    $BX
    $FCX
    $MELI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $ABBV
    $BX
    $FCX
    $MELI
    SEC Filings

    View All

    Large owner Blackstone Holdings Iv Gp Management (Delaware) L.P. bought $30,000,000 worth of Common Shares of Beneficial Interest (1,146,789 units at $26.16) (SEC Form 4)

    4 - Blackstone Inc. (0001393818) (Reporting)

    2/24/26 6:33:14 PM ET
    $BX
    Investment Managers
    Finance

    Director Porat Ruth bought $68,553 worth of shares (525 units at $130.68), increasing direct ownership by 1% to 39,502 units (SEC Form 4)

    4 - Blackstone Inc. (0001393818) (Issuer)

    2/20/26 4:12:44 PM ET
    $BX
    Investment Managers
    Finance

    Large owner Blackstone Holdings Iv Gp Management (Delaware) L.P. bought $10,000,000 worth of Common Shares of Beneficial Interest (384,468 units at $26.01) (SEC Form 4)

    4 - Blackstone Inc. (0001393818) (Reporting)

    12/22/25 4:59:31 PM ET
    $BX
    Investment Managers
    Finance

    AbbVie Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - AbbVie Inc. (0001551152) (Filer)

    2/26/26 5:14:40 PM ET
    $ABBV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 424B5 filed by AbbVie Inc.

    424B5 - AbbVie Inc. (0001551152) (Filer)

    2/26/26 5:07:32 PM ET
    $ABBV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form FWP filed by AbbVie Inc.

    FWP - AbbVie Inc. (0001551152) (Subject)

    2/26/26 4:36:00 PM ET
    $ABBV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABBV
    $BX
    $FCX
    $MELI
    Leadership Updates

    Live Leadership Updates

    View All

    Andy Anavi, Senior VP of Fintech Services, Discusses Mercado Pago's Ambitions and Competitive Advantages

    Mercado Libre (NASDAQ:MELI), the leading e-commerce and fintech platform in Latin America, today released the latest episode of its Investor Relations podcast series, "Inside Mercado Libre," "Fintech Services with Andy Anavi." In this episode, Richard Cathcart, Investor Relations Director, is joined by Andy Anavi, Senior VP of Fintech Services, to discuss the strategic evolution and growth opportunities of Mercado Pago. The conversation explores Mercado Pago's journey from a payments wallet to a fully-fledged digital bank, highlighting its leading NPS in Brazil, Mexico, and Argentina. Key topics include the company's focus on "principality"—becoming the primary financial relationship for

    1/28/26 12:21:00 PM ET
    $MELI
    Real Estate

    Mercado Libre's CFO, Martin de los Santos, Discusses Q3'2025 Results in Latest CFO Perspectives Episode

    Mercado Libre (NASDAQ:MELI), the leading e-commerce and fintech platform in Latin America, today released the latest episode of "CFO Perspectives," a series within the Inside Mercado Libre podcast. Following our Q3 earnings report, Chief Financial Officer Martin de los Santos reflects on Mercado Libre's performance this past quarter. He addresses key questions from investors, including early results of the lower free shipping threshold in Brazil, how management is thinking about balancing growth and profitability and fintech NPS in Brazil. Martin highlights, "This was a great quarter of growth delivering 39% year on year growth in revenues. It is the 27th consecutive quarter in which we d

    11/13/25 8:07:00 AM ET
    $MELI
    Real Estate

    Freeport Announces Appointment of Cory Stevens as President and Chief Operating Officer – Americas

    Freeport (NYSE:FCX) announced today that A. Cory Stevens has been named President and Chief Operating Officer of Freeport Americas, effective December 1, 2025. Stevens joined Freeport in 1997 and has held multiple leadership roles at the company's North and South America operations and most recently led the team responsible for developing Freeport's smelter project in Indonesia. He currently leads FCX's centralized technical organization, with responsibility for a broad range of technical support functions across the company, including engineering and construction activities, growth projects, including the high-impact innovative leach initiative, operational support and research and devel

    11/5/25 7:30:00 AM ET
    $FCX
    Metal Mining
    Basic Materials

    $ABBV
    $BX
    $FCX
    $MELI
    Financials

    Live finance-specific insights

    View All

    MercadoLibre, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

    MercadoLibre, Inc. (NASDAQ:MELI) (http://www.mercadolibre.com) today reported financial results for the fourth quarter and full year ended December 31, 2025, in a Letter to Shareholders, which is now posted to the company's Investor Relations website https://investor.mercadolibre.com. The Company will host its earnings video conference, as well as a conference call and audio webcast for any questions that investors may have, on February 24, at 5:00 p.m. Eastern Time. In order to access our video webcast and the live audio, investors, analysts and the market in general may access the following link at https://event.choruscall.com/mediaframe/webcast.html?webcastid=0TZ2mrjz to attend the l

    2/24/26 4:02:00 PM ET
    $MELI
    Real Estate

    AbbVie Declares Quarterly Dividend

    NORTH CHICAGO, Ill., Feb. 19, 2026 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE:ABBV) today declared a quarterly cash dividend of $1.73 per share.  The cash dividend is payable May 15, 2026, to stockholders of record at the close of business on April 15, 2026.Since the company's inception in 2013, AbbVie has increased its dividend by more than 330 percent. AbbVie is a member of the S&P Dividend Aristocrats Index, which tracks companies that have annually increased their dividend for at least 25 consecutive years.About AbbVieAbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of

    2/19/26 9:37:00 AM ET
    $ABBV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    MercadoLibre, Inc. to Report Fourth Quarter 2025 Financial Results

    MercadoLibre, Inc. (NASDAQ:MELI) (http://www.mercadolibre.com) announces that it intends to release financial results for its fourth fiscal quarter ending December 31, 2025, on February 24, 2026. The Company will host its earnings results video conference, as well as a conference call and audio webcast, on February 24, at 5:00 p.m. Eastern Time. In order to access our video webcast and the live audio, investors, analysts and the market in general may access the following link at https://event.choruscall.com/mediaframe/webcast.html?webcastid=0TZ2mrjz to attend the live event. To participate in our conference call Q&A, investors, analysts and the market in general may access the followi

    2/13/26 4:30:00 PM ET
    $MELI
    Real Estate

    $ABBV
    $BX
    $FCX
    $MELI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by Oxford Lane Capital Corp.

    SC 13D - Oxford Lane Capital Corp. (0001495222) (Subject)

    11/14/24 9:05:19 PM ET
    $OXLC
    Investment Managers
    Finance

    Amendment: SEC Form SC 13G/A filed by Oxford Lane Capital Corp.

    SC 13G/A - Oxford Lane Capital Corp. (0001495222) (Subject)

    11/13/24 4:22:02 PM ET
    $OXLC
    Investment Managers
    Finance

    SEC Form SC 13G filed by Blackstone Inc.

    SC 13G - Blackstone Inc. (0001393818) (Subject)

    11/13/24 3:07:30 PM ET
    $BX
    Investment Managers
    Finance